[Efficacy and safety evaluation of gemcitabine combined with oxaliplatin in lymphoma patients after failure of multiple chemotherapy regimens].
Lists
Only you see this
Abstract
GEMOX regimen can get a better response rate in lymphoma patients after failure of multiple chemotherapy regimens, and with a good tolerance and acceptable safety. Some patients can get long-term survival. Patients sensitive to the last chemotherapy are more likely to benefit from GEMOX regimen.
BibTeX
@inproceedings{yang2014efficacy,
author = {Jian-liang Yang and Yuankai Shi and Xiaohui He and Shengyu Zhou and Mei Dong and Peng Liu and Changgong Zhang and Yan Qin and Sheng Yang and Lin Gui},
title = {{[Efficacy and safety evaluation of gemcitabine combined with oxaliplatin in lymphoma patients after failure of multiple chemotherapy regimens].}},
booktitle = {PubMed},
year = {2014},
}Loading related content...